Pulse lineResearch With Heart Logo

ARIC Publications

Journal Article
Gross AL, Power MC, Albert MS, et al. "Application of Latent Variable Methods to the Study of Cognitive Decline When Tests Change over Time." Epidemiology. 2015;26(6):878-87.
Selvaraj S, Myhre PL, Vaduganathan M, et al. "Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community." JACC Heart Fail. 2020;8(8):640-653.
Ndumele CE, Matsushita K, Astor B, et al. "Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study." Eur J Prev Cardiol. 2014;21(7):866-75.
Shachter NS. "Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism." Curr Opin Lipidol. 2001;12(3):297-304.
Volcik KA, Barkley R A, Hutchinson RG, et al. "Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants." Am J Epidemiol. 2006;164(4):342-8.
Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. "Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations." Am J Hum Genet. 1994;54(2):341-60.
Selvaraj S, Claggett B, Johansen MC, et al. "Apolipoprotein E Polymorphism, Cardiac Remodeling, and Heart Failure in the ARIC Study." J Card Fail. 2022;28(7):1128-1136.
Surguchov AP, Boerwinkle E, Sharett AR, Patsch WP. "Apolipoprotein E genotype and lipid transport: insight into the role of the epsilon 4 allele." Atherosclerosis. 1994;106(1):119-21.
Sturgeon JD, Folsom AR, Bray MS, Boerwinkle E, Ballantyne CM. "Apolipoprotein E genotype and incident ischemic stroke: the Atherosclerosis Risk in Communities Study." Stroke. 2005;36(11):2484-6.
Boland LL, Folsom AR, Boerwinkle E. "Apolipoprotein E genotype and gallbladder disease risk in a large population-based cohort." Ann Epidemiol. 2006;16(10):763-9.
Liew G, Shankar A, Wang J J, et al. "Apolipoprotein E gene polymorphisms and retinal vascular signs: the atherosclerosis risk in communities (ARIC) study." Arch Ophthalmol. 2007;125(6):813-8.
Wong T Y, Shankar A, Klein R, et al. "Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study." Ophthalmology. 2006;113(2):255-9.
Hsu CC, Kao LWH, Coresh J, et al. "Apolipoprotein E and progression of chronic kidney disease." JAMA. 2005;293(23):2892-9.
Foster MC, Coresh JJ, Fornage M, et al. "APOL1 variants associate with increased risk of CKD among African Americans." J Am Soc Nephrol. 2013;24(9):1484-91.
Klos K, Shimmin L, Ballantyne C, et al. "APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels." Hum Mol Genet. 2008;17(13):2039-46.
Maxwell TJ, Ballantyne CM, Cheverud JM, Guild CS, Ndumele CE. "APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactions." Genetics. 2013;195(4):1397-405.
Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E. "APOE genotype and cognitive decline in a middle-aged cohort." Neurology. 2005;64(2):268-76.
Pokharel Y, Mouhanna F, Nambi V, et al. "ApoB, small-dense LDL-C, Lp(a), LpPLA activity, and cognitive change." Neurology. 2019;92(22):e2580-e2593.
Stone K, Fryer S, Faulkner J, et al. "The aortic-femoral arterial stiffness gradient is blood pressure independent in older adults: the atherosclerosis risk in communities (ARIC) study." J Hypertens. 2021.
Stone K, Fryer S, Meyer ML, et al. "The aortic-femoral arterial stiffness gradient: an atherosclerosis risk in communities (ARIC) study." J Hypertens. 2021.
Wei J, Palta P, Meyer ML, et al. "Aortic Stiffness and White Matter Microstructural Integrity Assessed by Diffusion Tensor Imaging: The ARIC-NCS." J Am Heart Assoc. 2020;9(6):e014868.
Conlan MG, Folsom AR, Finch A, et al. "Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Thromb Haemost. 1994;72(4):551-6.
Ding J, Davis-Plourde KL, Sedaghat S, et al. "Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies." Lancet Neurol. 2020;19(1):61-70.
Federspiel JJ, Sueta CA, Kucharska-Newton AMaria, et al. "Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study." J Eval Clin Pract. 2018;24(1):48-55.
Iso H, Folsom AR, Koike KA, et al. "Antigens of tissue plasminogen activator and plasminogen activator inhibitor 1: correlates in nonsmoking Japanese and Caucasian men and women." Thromb Haemost. 1993;70(3):475-80.
Runchey SS, Folsom AR, Tsai MY, Cushman M, McGovern PD. "Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study." Br J Haematol. 2002;119(4):1005-10.
Kshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. "Antibodies to periodontal organisms are associated with decreased kidney function. The Dental Atherosclerosis Risk In Communities study." Blood Purif. 2007;25(1):125-32.
Paskiewicz A, Wang FM, Yang C, et al. "Ankle-Brachial Index and Subsequent Risk of Severe Ischemic Leg Outcomes: The ARIC Study." J Am Heart Assoc. 2021;10(22):e021801.
Wang FM, Yang C, Ballew SH, et al. "Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2021;336:39-47.
Matsushita K, Ballew SH, Sang Y, et al. "Ankle-brachial index and physical function in older individuals: The Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2017;257:208-215.
Hua S, Loehr LR, Tanaka H, Heiss G, Coresh JJ, Selvin E. "Ankle-brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study." Cardiovasc Diabetol. 2016;15(1):163.
Reich LM, Heiss G, Boland LL, Hirsch AT, Wu K, Folsom AR. "Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort." Vasc Med. 2007;12(4):267-73.
Tsai AW, Folsom AR, Rosamond WD, Jones DW. "Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study." Stroke. 2001;32(8):1721-4.
Kshirsagar AV, Coresh J, Brancati F, Colindres RE. "Ankle brachial index independently predicts early kidney disease." Ren Fail. 2004;26(4):433-43.
Stitziel NO, Khera AV, Wang X, et al. "ANGPTL3 Deficiency and Protection Against Coronary Artery Disease." J Am Coll Cardiol. 2017;69(16):2054-2063.
Arnett DK, Borecki IB, Ludwig EH, et al. "Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: the atherosclerosis risk in communities and the NHLBI family heart studies." Atherosclerosis. 1998;138(1):111-6.
Golden S H, Williams JE, Ford DE, et al. "Anger temperament is modestly associated with the risk of type 2 diabetes mellitus: the Atheroslcerosis Risk in Communities Study." Psychoneuroendocrinology. 2006;31(3):325-32.
Williams JE, Paton CC, Siegler IC, Eigenbrodt ML, Nieto FJ, Tyroler HA. "Anger proneness predicts coronary heart disease risk: prospective analysis from the atherosclerosis risk in communities (ARIC) study." Circulation. 2000;101(17):2034-9.
Kucharska-Newton AMaria, Williams JE, Chang PP, Stearns SC, Sueta CA, Blecker SB. "Anger proneness, gender, and the risk of heart failure." J Card Fail. 2014;20(12):1020-6.
McAdams-Demarco MA, Maynard JW, Coresh J, Baer AN. "Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study." Arthritis Res Ther. 2012;14(4):R193.
Yeap BBeng, Marriott RJames, Adams RJ, et al. "Androgens In Men Study (AIMS): protocol for meta-analyses of individual participant data investigating associations of androgens with health outcomes in men." BMJ Open. 2020;10(5):e034777.
Li M, Li Y, Weeks O, et al. " and Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function." J Am Soc Nephrol. 2017;28(3):981-994.
Böger CA, Gorski M, McMahon GM, et al. " and Loci Associate with Plasma Osmolality." J Am Soc Nephrol. 2017;28(8):2311-2321.
Ma Y, Jun GR, Zhang X, et al. "Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype." JAMA Neurol. 2019.
Direk N, Williams S, Smith JA, et al. "An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype." Biol Psychiatry. 2017;82(5):322-329.
Tao R, Zeng D, Franceschini N, North KE, Boerwinkle E. "Analysis of Sequence Data Under Multivariate Trait-Dependent Sampling." J Am Stat Assoc. 2015;110(510):560-572.
Nandakumar P, Lee D, Hoffmann TJ, et al. "Analysis of putative cis-regulatory elements regulating blood pressure variation." Hum Mol Genet. 2020;29(11):1922-1932.
Carty CL, Bhattacharjee S, Haessler J, et al. "Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study." Circ Cardiovasc Genet. 2014;7(4):505-13.
Li AH, Morrison AC, Kovar C, et al. "Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease." Nat Genet. 2015;47(6):640-2.
Chambless LE, Davis V. "Analysis of associations with change in a multivariate outcome variable when baseline is subject to measurement error." Stat Med. 2003;22(7):1041-67.
Fu W, O'Connor TD, Jun G, et al. "Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants." Nature. 2013;493(7431):216-20.
Brody JA, Morrison AC, Bis JC, et al. "Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology." Nat Genet. 2017;49(11):1560-1563.
Charles BA, Hsieh MM, Adeyemo AA, et al. "Analyses of genome wide association data, cytokines, and gene expression in African-Americans with benign ethnic neutropenia." PLoS One. 2018;13(3):e0194400.
C Quarta C, Buxbaum JN, Shah AM, et al. "The amyloidogenic V122I transthyretin variant in elderly black Americans." N Engl J Med. 2015;372(1):21-9.
Hasbani NR, Ligthart S, Brown MR, et al. "American Heart Association's Life's Simple 7: Lifestyle Recommendations, Polygenic Risk, and Lifetime Risk of Coronary Heart Disease." Circulation. 2022;145(11):808-818.
Folsom AR, Shah AM, Lutsey PL, et al. "American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function." Am J Med. 2015;128(9):970-6.e2.
Mok Y, Sang Y, Ballew SH, et al. "American Heart Association's Life's Simple 7 at Middle Age and Prognosis After Myocardial Infarction in Later Life." J Am Heart Assoc. 2018;7(4).
Folsom AR, Olson NC, Lutsey PL, Roetker NS. "American Heart Association's Life's Simple 7 and incidence of venous thromboembolism." Am J Hematol. 2015;90(5):E92.
Garg PK, O'Neal WT, Chen LYee, Loehr LR, Sotoodehnia N, Soliman EZ. "American Heart Association's Life Simple 7 and Risk of Atrial Fibrillation in a Population Without Known Cardiovascular Disease: The ARIC (Atherosclerosis Risk in Communities) Study." J Am Heart Assoc. 2018;7(8).
Rooney MR, Tang O, Tcheugui JBEchouffo, et al. "American Diabetes Association Framework for Glycemic Control in Older Adults: Implications for Risk of Hospitalization and Mortality." Diabetes Care. 2021.
Beecham GW, Bis JC, Martin ER, et al. "The Alzheimer's Disease Sequencing Project: Study design and sample selection." Neurol Genet. 2017;3(5):e194.
Juraschek SP, Steffes MW, Miller ER, Selvin E. "Alternative markers of hyperglycemia and risk of diabetes." Diabetes Care. 2012;35(11):2265-70.
Raffield LM, Iyengar AK, Wang B, et al. "Allelic Heterogeneity at the CRP Locus Identified by Whole-Genome Sequencing in Multi-ancestry Cohorts." Am J Hum Genet. 2020;106(1):112-120.
Palmer ND, Kahali B, Kuppa A, et al. "Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction." Hum Mol Genet. 2021;30(15):1443-1456.
Ding J, Eigenbrodt ML, Mosley TH, et al. "Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community-based population of middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2004;35(1):16-21.
Eigenbrodt ML, Mosley TH, Hutchinson RG, Watson RL, Chambless LE, Szklo M. "Alcohol consumption with age: a cross-sectional and longitudinal study of the Atherosclerosis Risk in Communities (ARIC) study, 1987-1995." Am J Epidemiol. 2001;153(11):1102-11.
Demirovic J, Nabulsi A, Folsom AR, et al. "Alcohol consumption and ultrasonographically assessed carotid artery wall thickness and distensibility. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Circulation. 1993;88(6):2787-93.
Kao WH, Puddey IB, Boland LL, Watson RL, Brancati FL. "Alcohol consumption and the risk of type 2 diabetes mellitus: atherosclerosis risk in communities study." Am J Epidemiol. 2001;154(8):748-57.
Fuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G. "Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study." Hypertension. 2001;37(5):1242-50.
Daya NR, Rebholz CM, Appel LJ, Selvin E. "Alcohol Consumption and Risk of Hospitalizations and Mortality in the Atherosclerosis Risk in Communities Study." Alcohol Clin Exp Res. 2020;44(8):1646-1657.
Gonçalves A, Claggett B, Jhund PS, et al. "Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study." Eur Heart J. 2015;36(15):939-45.
Hu EA, Lazo M, Rosenberg SD, Grams ME, Steffen LM, Coresh JJ. "Alcohol Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities Study." J Ren Nutr. 2020;30(1):22-30.
He X, Rebholz CM, Daya N, Lazo M. "Alcohol consumption and incident diabetes: The Atherosclerosis Risk in Communities (ARIC) study." Diabetologia. 2019;62(5):770-778.
Lazo M, Chen Y, McEvoy JW, et al. "Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study." Clin Chem. 2016;62(9):1202-10.
Oelsner EC, Balte PP, Grams ME, et al. "Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study." Am J Respir Crit Care Med. 2019;199(3):321-332.
Mok Y, Ballew SH, Sang Y, Coresh JJ, Joshu CE, Platz EA. "Albuminuria, Kidney Function, and Cancer Risk in the Community." Am J Epidemiol. 2020;189(9):942-950.
Mok Y, Ballew SH, Stacey RBrandon, et al. "Albuminuria and Prognosis Among Individuals With Atherosclerotic Cardiovascular Disease: The ARIC Study." J Am Coll Cardiol. 2021;78(1):87-89.
Grams ME, Astor BC, Bash LD, Matsushita K, Wang Y, Coresh J. "Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury." J Am Soc Nephrol. 2010;21(10):1757-64.
Scheppach JB, Coresh JJ, Wu A, et al. "Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study." Am J Kidney Dis. 2020;76(6):775-783.
Li J, Agarwal SK, Alonso A, et al. "Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2014;129(9):971-80.